Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline
- Affiliated Author(s)
- 권상훈
- Alternative Author(s)
- Kwon, Sang Hoon
- Journal Title
- Journal of Gynecologic Oncology
- ISSN
- 2005-0399
- Issued Date
- 2019
- Keyword
- Papillomavirus Vaccines; Practice Guidelines; Female; Male
- Abstract
- In 2016, 9-valent human papillomavirus (HPV) vaccine has been newly introduced in Korea, thus the need to develop recommendations for the vaccine has raised. Until we decide to develop a guideline, no further studies on the bi-valent or quadri-valent HPV vaccine have been announced. We searched and reviewed the literatures focused on the efficacy of 9-valent HPV vaccine, the ideal age of 3-dose schedule vaccination, the efficacy of 9-valent HPV vaccine in middle-aged women, the efficacy of the 2-dose schedule vaccination, the safety of 9-valent HPV vaccine, the possibility of additional 9-valent HPV vaccination, and cross-vaccination of 9-valent HPV vaccine. So, Korean Society of Gynecologic Oncology (KSGO) developed a guideline only for 9-valent HPV vaccine.
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.